2026 Japan Cell Therapy Landscape: Ventures To Gain Presence With NDAs, IPOs

While several companies await regulatory approval decisions on their cell therapies in Japan, BioCardia proceeds with discussions on an NDA filing and Innovacel readies an IPO.